{"retracted":true,"title":"A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4(+) T cells in mice.","url":"http://doi.org/10.1124/jpet.112.193946","journal":"The Journal of pharmacology and experimental therapeutics","update":"retracted"}
